Femhrt

Product manufactured by Allergan, Inc.

Application Nr Approved Date Route Status External Links
NDA021065 2005-01-14 Oral RX Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Femhrt Is An Estrogen Plus Progestin Indicated In A Woman With A Uterus For: Treatment Of Moderate To Severe Vasomotor Symptoms Due To Menopause (1.1) Prevention Of Postmenopausal Osteoporosis (1.2) 1.1 Treatment Of Moderate To Severe Vasomotor Symptoms Due To Menopause 1.2 Prevention Of Postmenopausal Osteoporosis Limitation Of Use When Prescribing Solely For The Prevention Of Postmenopausal Osteoporosis, Therapy Should Only Be Considered For Women At Significant Risk Of Osteoporosis And Non-Estrogen Medication Should Be Carefully Considered.

All Formulated Excipients (2 Total)

Name Structure Kind Function Status
1. Calcium Stearate CALCIUM STEARATE Molecular AC-Anticaking agent , AF-Antifoaming (or defoaming) agent , MISC-Miscellaneous GRAS-Generally recognized as safe.
2. Lactose Monohydrate LACTOSE MONOHYDRATE Molecular

Active Ingredients ( 2 Total)

Name Structure ZINC ID(s)
1. Ethinyl Estradiol
2. Norethindrone Acetate

Comments